US House hearing on coronavirus vaccines produces little drama, but a question on school reopenings underscores the difficult position that industry finds itself in during the pandemic – and how its more routine business model has deep challenges as well.
The vaccine bunch – participants in the House Energy and Commerce/Oversight and Investigations Subcommittee hearing on COVID vaccines, 21 July 2020. Clockwise from the top left: Moderna’s Stephen Hoge, Pfizer’s John Young, Johnson & Johnson’s Macaya Douoguih, AstraZeneca’s Mene Pangalos, Merck’s Julie Gerberding, Rep. Raul Ruiz (D-CA), Rep. David McKinley (R-WV), a masked Rep. Greg Walden (R-OR), and in the center square, subcommittee chair Diana DeGette (D-CO) is pictured swearing in the witnesses. • Source: photo illustration from screenshots of hearing feed
